science

20312 readers

564 users here now

A community to post scientific articles, news, and civil discussion.

rule #1: be kind

founded 2 years ago

MODERATORS

[email protected]

184

Shroom compound psilocybin shows promise for bipolar disorder in early trial (www.livescience.com)

submitted 2 years ago by [email protected] to c/[email protected]

10 comments fedilink hide all child comments

top 10 comments

sorted by: hot top controversial new old

[–] [email protected] 26 points 2 years ago (2 children)

Basically every time a psilocybin study is conducted for use in mental health applications it's found to be beneficial. It's just that the DEA doesn't give a fuck and refuse to change the schedule of the drug even with countless studies showing it's effectiveness, as well as countless doctors, researchers, and institutes recommending they reduce psilocybin to schedule III.

Also, we all know what they were doing with that thumbnail.

[–] [email protected] 9 points 2 years ago (3 children)

I'm feeling stupid this morning, what were they doing with the thumbnail?

[–] [email protected] 5 points 2 years ago

? Not sure what the color filter is called, but it's an upside down mushroom.

[–] [email protected] 4 points 2 years ago

I guess it depends on what view and what app your using, but on my phone with a small thumbnail in list view it looks like a butthole.

[–] [email protected] 3 points 2 years ago

Looks like a sharpie in the pooper

[–] [email protected] 3 points 2 years ago (1 children)

I think the issue is a bit more than the DEA not wanting to move, and it's also related to how many studies showing positive effects of psychedelics have severe methodological or other important issues. This podcast summarizes some of those issues very nicely in case anyone's interested: https://www.thestudiesshowpod.com/p/episode-4-psychedelics

[–] [email protected] 3 points 2 years ago

I'll listen to the podcast because I'm sure there's info in it that will be new to me, but I do know drug scheduling creates a purgatory that makes substances difficult to research. When the scheduling means that it can't be produced in amounts to create meaningful clinical studies, the "drugs with no currently accepted medical use" definition is difficult to get out of.

To add on to that, if John Hopkins research labs, the same one that came up with CPR, water purification, and genetic engineering, thinks psilocybin has medical use and merit, I believe them.

[–] [email protected] 21 points 2 years ago (1 children)

While I'm all for descheduling psilocybin (and decriminalizing it as well), it should be noted that this was a very small sample size study (15 people) and I've heard anecdotal warnings to not take shrooms if bipolar or schizophrenic for years, as there might be a slight risk of psychosis.

[–] [email protected] 18 points 2 years ago

You also have to take into account the setting the test was administered in. The participants underwent therapy before, during, and after the treatment. Being in a safe space with immediate access to mental health professionals probably decreases the risks substantially.

[–] [email protected] 2 points 2 years ago

feel different? cured. same way they tested current benzos